The ASRA releases its fifth iteration of evidence-based guidelines on regional anesthesia in patients on antithrombotic or ...

Results from the AZALEA-TIMI 71 phase 2 trial showed great promise for abelacimab to transform care for high-risk patients with atrial fibrillation.

Compared with non-anticoagulated patients, patients with anticoagulation-associated ICH had higher GFAP values. Cutoff points were ascertained, which facilitated ICH diagnosis across age groups ...

Background Differences in the clinical outcomes and level of risk among Asian versus non-Asian patients with atrial ...

Kevin McVary, Timothy McClure, and Kevin Zorn explore BPH management through case scenarios, examining medical therapy, minimally invasive techniques, and PAE's role. They address anticoagulated ...